Alpine Global Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,940
Closed -$1.31M 298
2020
Q2
$1.31M Buy
+12,940
New +$1.16M 0.23% 73
2018
Q4
Sell
-10,252
Closed -$367K 243
2018
Q3
$367K Buy
+10,252
New +$318K 0.07% 57
2015
Q4
Sell
-12,364
Closed -$265K 133
2015
Q3
$265K Sell
12,364
-39,880
-76% -$890K 0.08% 68
2015
Q2
$1.04M Buy
+52,244
New +$918K 0.18% 99

Other funds holding DXCM

Alpine Global Management's DXCM Position: Q3 2020 in Review

Alpine Global Management sold out of DexCom (DXCM) in Q3 2020, closing a stake of 12,940 shares — an estimated $1.31M sold.

Alpine Global Management first reported a position in DXCM in Q2 2015 and held it in 4 quarters. The position peaked at $1.31M in Q2 2020. 728 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

  • Alpine Global Management reported no remaining DexCom position as of Q3 2020 after selling out during the quarter.
  • Alpine Global Management sold 12,940 DexCom shares in Q3 2020, an estimated $1.31M.
  • Alpine Global Management first reported a position in DexCom in Q2 2015 and held it in 4 quarters.
  • Alpine Global Management's DexCom position peaked at $1.31M in Q2 2020.
  • 728 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on Alpine Global Management's 13F filing for Q3 2020, filed 12 Nov 2020.